The new Idea Tracker capability further improves the efficiency of drug discovery by supporting project management, idea sharing and molecule design tracking.
Samsung Bio pulls in $1.06B manufacturing deal with unnamed US pharma company
Samsung Biologics has signed a manufacturing contract worth 1.46 trillion won ($1.06 billion) with an unnamed “large” US pharmaceutical company, making this at least the